Position in VIR
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$5,924,625
+$853,189 QoQ
Shares Held
581,416
+2.7% QoQ
Ownership
0.344%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#43
of 237 holders
Holding Since
Sep 2020
21 quarters on record
Voting authority
Sole 99%
Shared 0%
None 1%
Common Shares in VIR Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026AQR CAPITAL MANAGEMENT LLC holds $5,658,888,286 across 216 Biotechnology names. VIR ranks #75 (0.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,126,080 | $702,155,918 | |
| 2 | INCY |
Incyte Corp
|
5,320,901 | $603,177,333 | |
| 3 | EXEL |
Exelixis, Inc.
|
11,023,943 | $599,812,735 | |
| 4 | JAZZ |
Jazz Pharmaceuticals plc
|
1,522,568 | $366,893,205 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
5,699,541 | $326,127,732 | |
| 6 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
616,170 | $306,070,117 | |
| 7 | RVMD |
Revolution Medicines, Inc.
|
1,295,450 | $242,611,869 | |
| 8 | RPRX |
Royalty Pharma plc
|
4,305,412 | $241,404,446 |
All Filings in VIR
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,924,625 | 581,416 | Shares | Other | 2026-08-14 | |
| 2026-03-31 | $5,071,436 | 566,009 | Shares | Other | 2026-05-15 | |
| 2025-12-31 | $1,123,531 | 186,324 | Shares | Other | 2026-02-17 | |
| 2025-09-30 | $868,707 | 152,138 | Shares | Other | 2025-11-14 | |
| 2025-06-30 | $2,261,975 | 448,805 | Shares | Other | 2025-08-14 | |
| 2025-03-31 | $1,738,562 | 268,297 | Shares | Other | 2025-05-15 | |
| 2024-12-31 | $89,987 | 12,260 | Shares | Other | 2025-02-14 | |
| 2024-09-30 | $126,745 | 16,922 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $133,829 | 15,037 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $263,976 | 26,059 | Shares | Other | 2024-05-15 | |
| 2023-12-31 | $206,159 | 20,493 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $842,128 | 89,875 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $7,122,432 | 290,356 | Shares | Defined | 2023-08-14 | |
| 2023-03-31 | $7,857,627 | 337,672 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $7,812,513 | 308,673 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $6,800,692 | 352,733 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,341,288 | 209,709 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $2,818,140 | 109,570 | Shares | Defined | 2022-05-16 | |
| 2021-09-30 | $413,352 | 9,498 | Shares | Defined | 2021-11-15 | |
| 2021-03-31 | $620,930 | 12,111 | Shares | Defined | 2021-05-17 | |
| 2020-09-30 | $739,571 | 21,543 | Shares | Defined | 2020-11-16 | |
| No filing history on record for this holder in this stock. | ||||||